Advertisement
Review Article| Volume 36, ISSUE 4, P721-744, December 2016

Ketamine

A Cause of Urinary Tract Dysfunction

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. 2014 National Survey on Drug Use and Health: Detailed Tables. 2015. Available at: http://www.samhsa.gov/data/s ites/default/files/NSDUH-DetTabs2014/NSDUH-DetTabs2014.pdf. Accessed June 5, 2016.

        • Koob G.F.
        • Mason B.J.
        Existing and future drugs for the treatment of the dark side of addiction.
        Annu Rev Pharmacol Toxicol. 2016; 56: 299-322
        • Piazza P.V.
        • Deroche V.
        • Deminière J.M.
        • et al.
        Corticosterone in the range of stress-induced levels possesses reinforcing properties: implications for sensation-seeking behaviors.
        Proc Natl Acad Sci U S A. 1993; 90: 11738-11742
        • Valdez G.R.
        • Koob G.F.
        Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism.
        Pharmacol Biochem Behav. 2004; 79: 671-689
        • Koob G.F.
        Addiction is a reward deficit and stress surfeit disorder.
        Front Psychiatry. 2013; 4: 72
        • D'Souza M.S.
        Glutamatergic transmission in drug reward: implications for drug addiction.
        Front Neurosci. 2015; 9: 404
        • Boscarino J.A.
        • Hoffman S.N.
        • Han J.J.
        Opioid-use disorder among patients on long-term opioid therapy: impact of final DSM-5 diagnostic criteria on prevalence and correlates.
        Subst Abuse Rehabil. 2015; 6: 83-91
        • Lynch K.L.
        • Shapiro B.J.
        • Coffa D.
        • et al.
        Promethazine use among chronic pain patients.
        Drug Alcohol Depend. 2015; 150: 92-97
        • Muetzelfeldt L.
        • Kamboj S.K.
        • Rees H.
        • et al.
        Journey through the K-hole: phenomenological aspects of ketamine use.
        Drug Alcohol Depend. 2008; 95: 219-229
        • Chu P.S.
        • Kwok S.C.
        • Lam K.M.
        • et al.
        'Street ketamine'-associated bladder dysfunction: a report of ten cases.
        Hong Kong Med J. 2007; 13: 311-313
        • Bergman S.A.
        Ketamine: review of its pharmacology and its use in pediatric anesthesia.
        Anesth Prog. 1999; 46: 10-20
        • Anis N.A.
        • Berry S.C.
        • Burton N.R.
        • et al.
        The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate.
        Br J Pharmacol. 1983; 79: 565-575
      2. Ketamine (INN): update review report. Geneva. 2015.

        • Gu X.
        • Zhou L.
        • Lu W.
        An NMDA receptor-dependent mechanism underlies inhibitory synapse development.
        Cell Rep. 2016; 14: 471-478
        • Olney J.W.
        • Farber N.B.
        Glutamate receptor dysfunction and schizophrenia.
        Arch Gen Psychiatry. 1995; 52: 998-1007
      3. 35th Expert Committee on Drug Dependence, W.H.O. Ketamine: Expert peer review on critical review report (2). 2012. Available at: http://www.who.int/medicines/areas/quality_safety/4.2.2ExpertreviewKetaminecriticalreview.pdf. Accessed June 5, 2016.

      4. Ketamine (Street names: Special K, “K”, Kit Kat, Cat Valium). 2013. Available at: http://www.deadiversion.usdoj.gov/drug_chem_info/ketamine.pdf. Accessed June 5, 2016.

      5. United States Drug Enforcement Administration, U.S.D.o.J. Available from: Available at: http://www.dea.gov/druginfo/ds.shtml. Accessed June 5, 2016.

        • Ho C.C.
        • Pezhman H.
        • Praveen S.
        • et al.
        Ketamine-associated ulcerative cystitis: a case report and literature review.
        Malays J Med Sci. 2010; 17: 61-65
        • Joe Laidler K.A.
        The rise of club drugs in a heroin society: the case of Hong Kong.
        Subst Use Misuse. 2005; 40: 1257-1278
        • Leung K.S.
        • Li J.H.
        • Tsay W.I.
        • et al.
        Dinosaur girls, candy girls, and Trinity: voices of Taiwanese club drug users.
        J Ethn Subst Abuse. 2008; 7: 237-257
        • Chu P.S.
        • Ma W.K.
        • Wong S.C.
        • et al.
        The destruction of the lower urinary tract by ketamine abuse: a new syndrome?.
        BJU Int. 2008; 102: 1616-1622
        • Lai Y.
        • Wu S.
        • Ni L.
        • et al.
        Ketamine-associated urinary tract dysfunction: an underrecognized clinical entity.
        Urol Int. 2012; 89: 93-96
        • Lin H.C.
        • Lee H.S.
        • Chiueh T.S.
        • et al.
        Histopathological assessment of inflammation and expression of inflammatory markers in patients with ketamine-induced cystitis.
        Mol Med Rep. 2015; 11: 2421-2428
        • Yee C.H.
        • Lai P.T.
        • Lee W.M.
        • et al.
        Clinical outcome of a prospective case series of patients with ketamine cystitis who underwent standardized treatment protocol.
        Urology. 2015; 86: 236-243
        • Yek J.
        • Sundaram P.
        • Aydin H.
        • et al.
        The clinical presentation and diagnosis of ketamine-associated urinary tract dysfunction in Singapore.
        Singapore Med J. 2015; 56: 660-665
        • Lankenau S.E.
        • Clatts M.C.
        Drug injection practices among high-risk youths: the first shot of ketamine.
        J Urban Health. 2004; 81: 232-248
        • Lankenau S.E.
        • Clatts M.C.
        Ketamine injection among high risk youth: preliminary findings from New York City.
        J Drug Issues. 2002; 32: 893-905
        • Adamowicz P.
        • Kala M.
        Urinary excretion rates of ketamine and norketamine following therapeutic ketamine administration: method and detection window considerations.
        J Anal Toxicol. 2005; 29: 376-382
        • Zhang M.W.
        • Harris K.M.
        • Ho R.C.
        Is off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications.
        BMC Med Ethics. 2016; 17: 4
      6. Drugs and Human Performance Fact Sheet. Available at: http://www.nhtsa.gov/people/injury/research/job185drugs/ketamine.htm. Accessed June 5, 2016.

        • Jhang J.F.
        • Hsu Y.H.
        • Kuo H.C.
        Possible pathophysiology of ketamine-related cystitis and associated treatment strategies.
        Int J Urol. 2015; 22: 816-825
        • Avinash De Sousa A.P.
        • Macheswalla Y.
        Ketamine dependence: case report and review.
        J Pak Psychiatr Soc. 2010; 7: 1
      7. Critical Review of Ketamine. 2006.

      8. Ketamine, in AccessMedicine: Drug Monographs.

        • Shahani R.
        • Streutker C.
        • Dickson B.
        • et al.
        Ketamine-associated ulcerative cystitis: a new clinical entity.
        Urology. 2007; 69: 810-812
        • Mion G.
        • Villevieille T.
        Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings).
        CNS Neurosci Ther. 2013; 19: 370-380
        • Lo J.N.
        • Cumming J.F.
        Interaction between sedative premedicants and ketamine in man in isolated perfused rat livers.
        Anesthesiology. 1975; 43: 307-312
        • Chen C.Y.
        • Lee M.R.
        • Cheng F.C.
        • et al.
        Determination of ketamine and metabolites in urine by liquid chromatography-mass spectrometry.
        Talanta. 2007; 72: 1217-1222
        • Moore K.A.
        • Sklerov J.
        • Levine B.
        • et al.
        Urine concentrations of ketamine and norketamine following illegal consumption.
        J Anal Toxicol. 2001; 25: 583-588
        • Parkin M.C.
        • Turfus S.C.
        • Smith N.W.
        • et al.
        Detection of ketamine and its metabolites in urine by ultra high pressure liquid chromatography-tandem mass spectrometry.
        J Chromatogr B Analyt Technol Biomed Life Sci. 2008; 876: 137-142
        • Moreno I.
        • Barroso M.
        • Martinho A.
        • et al.
        Determination of ketamine and its major metabolite, norketamine, in urine and plasma samples using microextraction by packed sorbent and gas chromatography-tandem mass spectrometry.
        J Chromatogr B Analyt Technol Biomed Life Sci. 2015; 1004: 67-78
        • Favretto D.
        • Vogliardi S.
        • Tucci M.
        • et al.
        Occupational exposure to ketamine detected by hair analysis: a retrospective and prospective toxicological study.
        Forensic Sci Int. 2016; 265: 193-199
        • Lian K.
        • Zhang P.
        • Niu L.
        • et al.
        A novel derivatization approach for determination of ketamine in urine and plasma by gas chromatography-mass spectrometry.
        J Chromatogr A. 2012; 1264: 104-109
        • Halberstadt A.L.
        • Slepak N.
        • Hyun J.
        • et al.
        The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents.
        Psychopharmacology (Berl). 2016; 233: 1215-1225
        • Backberg M.
        • Beck O.
        • Helander A.
        Phencyclidine analog use in Sweden–intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project.
        Clin Toxicol (Phila). 2015; 53: 856-864
        • Storr T.M.
        • Quibell R.
        Can ketamine prescribed for pain cause damage to the urinary tract?.
        Palliat Med. 2009; 23: 670-672
        • Geisslinger G.
        • Hering W.
        • Thomann P.
        • et al.
        Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method.
        Br J Anaesth. 1993; 70: 666-671
        • Hamza J.
        • Ecoffey C.
        • Gross J.B.
        Ventilatory response to CO2 following intravenous ketamine in children.
        Anesthesiology. 1989; 70: 422-425
        • Li J.H.
        • Vicknasingam B.
        • Cheung Y.W.
        • et al.
        To use or not to use: an update on licit and illicit ketamine use.
        Subst Abuse Rehabil. 2011; 2: 11-20
        • Roelofse J.A.
        • Roelofse P.G.
        Oxygen desaturation in a child receiving a combination of ketamine and midazolam for dental extractions.
        Anesth Prog. 1997; 44: 68-70
        • Mattila M.A.
        • Larni H.M.
        • Nummi S.E.
        • et al.
        Effect of diazepam on emergence from ketamine anaesthesia. A double-blind study.
        Anaesthesist. 1979; 28: 20-23
        • Hanno P.
        • Dmochowski R.
        Status of international consensus on interstitial cystitis/bladder pain syndrome/painful bladder syndrome: 2008 snapshot.
        Neurourol Urodyn. 2009; 28: 274-286
        • Berry S.H.
        • Elliott M.N.
        • Suttorp M.
        • et al.
        Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States.
        J Urol. 2011; 186: 540-544
        • Clemens J.Q.
        • Link C.L.
        • Eggers P.W.
        • et al.
        Prevalence of painful bladder symptoms and effect on quality of life in black, Hispanic and white men and women.
        J Urol. 2007; 177: 1390-1394
        • Birder L.A.
        • Andersson K.E.
        • Kanai A.J.
        • et al.
        Urothelial mucosal signaling and the overactive bladder-ICI-RS 2013.
        Neurourol Urodyn. 2014; 33: 597-601
        • Katnik-Prastowska I.
        • Lis J.
        • Matejuk A.
        Glycosylation of uroplakins. Implications for bladder physiopathology.
        Glycoconj J. 2014; 31: 623-636
        • Lazzeri M.
        The physiological function of the urothelium–more than a simple barrier.
        Urol Int. 2006; 76: 289-295
        • Langbein L.
        • Grund C.
        • Kuhn C.
        • et al.
        Tight junctions and compositionally related junctional structures in mammalian stratified epithelia and cell cultures derived therefrom.
        Eur J Cell Biol. 2002; 81: 419-435
        • Acharya P.
        • Beckel J.
        • Ruiz W.G.
        • et al.
        Distribution of the tight junction proteins ZO-1, occludin, and claudin-4, -8, and -12 in bladder epithelium.
        Am J Physiol Renal Physiol. 2004; 287: F305-F318
        • Liu K.M.
        • Chuang S.M.
        • Long C.Y.
        • et al.
        Ketamine-induced ulcerative cystitis and bladder apoptosis involve oxidative stress mediated by mitochondria and the endoplasmic reticulum.
        Am J Physiol Renal Physiol. 2015; 309: F318-F331
        • Wu X.R.
        • Kong X.P.
        • Pellicer A.
        • et al.
        Uroplakins in urothelial biology, function, and disease.
        Kidney Int. 2009; 75: 1153-1165
        • Smith N.J.
        • Hinley J.
        • Varley C.L.
        • et al.
        The human urothelial tight junction: claudin 3 and the ZO-1alpha switch.
        Bladder (San Franc). 2015; 2: e9
        • de Groat W.C.
        • Yoshimura N.
        Afferent nerve regulation of bladder function in health and disease.
        Handb Exp Pharmacol. 2009; : 91-138
        • Chai T.C.
        • Russo A.
        • Yu S.
        • et al.
        Mucosal signaling in the bladder.
        Auton Neurosci. 2015; ([Epub ahead of print])
        • Kanai A.
        • Andersson K.E.
        Bladder afferent signaling: recent findings.
        J Urol. 2010; 183: 1288-1295
        • Hill W.G.
        Control of urinary drainage and voiding.
        Clin J Am Soc Nephrol. 2015; 10: 480-492
        • Charrua A.
        • Cruz C.D.
        • Cruz F.
        • et al.
        Transient receptor potential vanilloid subfamily 1 is essential for the generation of noxious bladder input and bladder overactivity in cystitis.
        J Urol. 2007; 177: 1537-1541
        • Colebunders B.
        • Van Erps P.
        Cystitis due to the use of ketamine as a recreational drug: a case report.
        J Med Case Rep. 2008; 2: 219
        • Chen C.H.
        • Lee M.H.
        • Chen Y.C.
        • et al.
        Ketamine-snorting associated cystitis.
        J Formos Med Assoc. 2011; 110: 787-791
        • Mason K.
        • Cottrell A.M.
        • Corrigan A.G.
        • et al.
        Ketamine-associated lower urinary tract destruction: a new radiological challenge.
        Clin Radiol. 2010; 65: 795-800
        • Tan S.
        • Chan W.M.
        • Wai M.S.
        • et al.
        Ketamine effects on the urogenital system–changes in the urinary bladder and sperm motility.
        Microsc Res Tech. 2011; 74: 1192-1198
        • Lee C.L.
        • Jiang Y.H.
        • Kuo H.C.
        Increased apoptosis and suburothelial inflammation in patients with ketamine-related cystitis: a comparison with non-ulcerative interstitial cystitis and controls.
        BJU Int. 2013; 112: 1156-1162
        • Gu D.
        • Huang J.
        • Yin Y.
        • et al.
        Long-term ketamine abuse induces cystitis in rats by impairing the bladder epithelial barrier.
        Mol Biol Rep. 2014; 41: 7313-7322
        • Song M.
        • Yu H.Y.
        • Chun J.Y.
        • et al.
        The fibrosis of ketamine, a noncompetitive N-methyl-d-aspartic acid receptor antagonist dose-dependent change in a ketamine-induced cystitis rat model.
        Drug Chem Toxicol. 2016; 39: 206-212
        • Zeng M.
        • Huang L.
        • Tang Z.
        • et al.
        A preliminary study on mechanisms for urinary system disorders before and after ketamine withdrawal in rats.
        Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2015; 40 ([in Chinese]): 269-275
        • Yong G.L.
        • Kong C.Y.
        • Ooi M.W.
        • et al.
        Resonance metallic ureteric stent in a case of ketamine bladder induced bilateral ureteric obstruction with one year follow up.
        Int J Surg Case Rep. 2015; 8c: 49-51
        • Kluck R.M.
        • Bossy-Wetzel E.
        • Green D.R.
        • et al.
        The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis.
        Science. 1997; 275: 1132-1136
        • Budd S.L.
        • Tenneti L.
        • Lishnak T.
        • et al.
        Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons.
        Proc Natl Acad Sci U S A. 2000; 97: 6161-6166
        • DiMauro S.
        • Schon E.A.
        Mitochondrial respiratory-chain diseases.
        N Engl J Med. 2003; 348: 2656-2668
        • Susin S.A.
        • Zamzami N.
        • Castedo M.
        • et al.
        Bcl-2 inhibits the mitochondrial release of an apoptogenic protease.
        J Exp Med. 1996; 184: 1331-1341
        • Yang J.
        • Liu X.
        • Bhalla K.
        • et al.
        Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.
        Science. 1997; 275: 1129-1132
        • Wu P.
        • Shan Z.
        • Wang Q.
        • et al.
        Involvement of mitochondrial pathway of apoptosis in urothelium in ketamine-associated urinary dysfunction.
        Am J Med Sci. 2015; 349: 344-351
        • Huang L.
        • Tang Z.
        • Li D.
        • et al.
        Ketamine induces apoptosis of human uroepithelial SV-HUC-1 cells.
        Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2014; 39 ([in Chinese]): 703-707
        • Bureau M.
        • Pelletier J.
        • Rousseau A.
        • et al.
        Demonstration of the direct impact of ketamine on urothelium using a tissue engineered bladder model.
        Can Urol Assoc J. 2015; 9: E613-E617
        • Flodby P.
        • Li C.
        • Liu Y.
        • et al.
        GRP78 regulates ER homeostasis and distal epithelial cell survival during lung development.
        Am J Respir Cell Mol Biol. 2016; 55: 135-149
        • Baker S.C.
        • Stahlschmidt J.
        • Oxley J.
        • et al.
        Nerve hyperplasia: a unique feature of ketamine cystitis.
        Acta Neuropathol Commun. 2013; 1: 64
        • Abraham P.
        • Rabi S.
        • Selvakumar D.
        Protective effect of aminoguanidine against oxidative stress and bladder injury in cyclophosphamide-induced hemorrhagic cystitis in rat.
        Cell Biochem Funct. 2009; 27: 56-62
        • Chien C.T.
        • Yu H.J.
        • Lin T.B.
        • et al.
        Substance P via NK1 receptor facilitates hyperactive bladder afferent signaling via action of ROS.
        Am J Physiol Renal Physiol. 2003; 284: F840-F851
        • Juan Y.S.
        • Lee Y.L.
        • Long C.Y.
        • et al.
        Translocation of NF-kappaB and expression of cyclooxygenase-2 are enhanced by ketamine-induced ulcerative cystitis in rat bladder.
        Am J Pathol. 2015; 185: 2269-2285
        • Wu P.
        • Wang Q.
        • Huang Z.
        • et al.
        Clinical staging of ketamine-associated urinary dysfunction: a strategy for assessment and treatment.
        World J Urol. 2016; 34: 1329-1336